| For: | Zhang CY, Liu S, Yang M. Treatment of liver fibrosis: Past, current, and future. World J Hepatol 2023; 15(6): 755-774 [PMID: 37397931 DOI: 10.4254/wjh.v15.i6.755] |
|---|---|
| URL: | https://www.wjgnet.com/1949-8454/full/v15/i6/755.htm |
| Number | Citing Articles |
| 1 |
G. P. Belyaev, A. B. Vyshtakalyuk, A. A. Parfenov, I. V. Galyametdinova, V. E. Semenov, V. V. Zobov. Xymedon and its conjugate with L-ascorbic acid for treating experimentally induced liver fibrosis in rats. Uchenye Zapiski Kazanskogo Universiteta Seriya Estestvennye Nauki 2025; 167(2) doi: 10.26907/2542-064X.2025.2.276-296
|
| 2 |
Muhammad Yasir Naeem, Tabinda Ijaz. Nutraceuticals for the prevention of liver fibrosis in metabolic dysfunction-associated steatotic liver disease (MASLD). Food Science and Biotechnology 2026; doi: 10.1007/s10068-026-02236-3
|
| 3 |
Girish L. Gupte, Anshu Srivastava. Chronic Liver Disease in Children: From Diagnosis to Liver Transplantation. Indian Journal of Pediatrics 2024; 91(3) doi: 10.1007/s12098-024-05030-3
|
| 4 |
Donglin Liu, Xinghua Xiong, Pengguo Chen. Nurr1 attenuates hepatic stellate cell activation by inhibiting EMT and cell cycle progression via interaction with Smad3. Molecular Biology Reports 2025; 52(1) doi: 10.1007/s11033-025-10896-3
|
| 5 |
Arndt Vogel, Robert C. Grant, Tim Meyer, Gonzalo Sapisochin, Grainne M. O’Kane, Anna Saborowski. Adjuvant and neoadjuvant therapies for hepatocellular carcinoma. Hepatology 2025; 82(3) doi: 10.1097/HEP.0000000000000726
|
| 6 |
Shubham Singh, Satendra Kumar Nirala, Prashant Singh, Monika Bhadauria.
Propolis ameliorates thioacetamide induced hepatic fibrosis in rats: an
in vivo
and
in silico
approach
. Drug and Chemical Toxicology 2026; 49(4) doi: 10.1080/01480545.2025.2608785
|
| 7 |
Sayed H. Seif el-Din, Olfat A. Hammam, Shahira M. Ezzat, Samira Saleh, Marwa M. Safar, Walaa H. El-Maadawy, Naglaa M. El-Lakkany. Hydroxysafflor yellow A protects against thioacetamide-induced liver fibrosis in rats via suppressing proinflammatory/fibrogenic mediators and promoting hepatic stellate cell senescence and apoptosis. Asian Pacific Journal of Tropical Biomedicine 2023; 13(8) doi: 10.4103/2221-1691.383689
|
| 8 |
Nidal Jaradat, Mohammed Hawash, Majid Sharifi-Rad, Ali Shakhshir, Shorooq Sobuh, Fatima Hussein, Linda Issa, Sondos Hamamrhe, Eman Al-Sheikh, Alaa Naser Ibrahim. Insights into free radicals scavenging, α-Amylase inhibition, cytotoxic and antifibrotic activities unveiled by Peganum harmala extracts. BMC Complementary Medicine and Therapies 2024; 24(1) doi: 10.1186/s12906-024-04602-2
|
| 9 |
Jong Min An, Hyunyoung Choi, Hyo In Kim, Do‐Yeon Kim, Jahyun Kim, Jinbong Park, Junyang Jung, Na Young Jeong, Dokyoung Kim. Programmed Aggregation of Lipidated Nitrobenzoselenadiazole as a Photo‐Activatable Pyroptosis Inducer. Advanced Healthcare Materials 2025; 14(24) doi: 10.1002/adhm.202501567
|
| 10 |
Pegah Hasanzade, Ghasem Mosayebi, Ali Ganji, Shohreh Fahimirad, Ali Ghazavi. Curcumin-loaded chitosan nanoparticles: a promising approach to liver fibrosis prevention. BMC Pharmacology and Toxicology 2025; 26(1) doi: 10.1186/s40360-025-01031-w
|
| 11 |
Mohamad Jamalinia, Ralf Weiskirchen, Amedeo Lonardo. Liver Fibrosis and the Risks of Impaired Cognition and Dementia: Mechanisms, Evidence, and Clinical Implications. Medical Sciences 2026; 14(1) doi: 10.3390/medsci14010044
|
| 12 |
Hongshan Huang. Targeting the CCL5/CCR5-PI3K-AKT axis suppresses hepatic stellate cell-induced breast cancer metastasis. Cancer Cell International 2026; 26(1) doi: 10.1186/s12935-026-04295-2
|
| 13 |
Aneta Sokal-Dembowska, Sara Jarmakiewicz-Czaja, Katarzyna Ferenc, Rafał Filip. Can Nutraceuticals Support the Treatment of MASLD/MASH, and thus Affect the Process of Liver Fibrosis?. International Journal of Molecular Sciences 2024; 25(10) doi: 10.3390/ijms25105238
|
| 14 |
Muhammad Shahzil, Fariha Hasan, Syeda Kanza Kazmi, Manesh Kumar Gangwani, UmmeSalma Shabbar, Ammad Javaid Chaudhary, Muhammad Ali Khaqan, Muhammad Saad Faisal, Kathy N. Williams, Babu P. Mohan, Christina Tofani. Evaluating the Effectiveness of Pegbelfermin in MASH‐Associated Hepatic Fibrosis A Meta‐Analysis and Systematic Review of Randomized Controlled Trials. JGH Open 2025; 9(3) doi: 10.1002/jgh3.70131
|
| 15 |
Ankita Wal, Azhar Rasheed, Pranay Wal, Manish Ramesh Bhise, Manisha Parmar, Deepak Nathiya, Rajesh Sharma, Amin Gasmi. The Therapeutic Potential of TGF-β as a Target for Multiple Chronic Diseases: A Comprehensive Review of Pharmacologically Approved Drugs and Investigational Agents. Current Signal Transduction Therapy 2025; 20(2) doi: 10.2174/0115743624339476250212114656
|
| 16 |
V. U. Lakshmi, S. Rajalakshmi, Aswathy Regunath, Gowri Parvathi R. Nair, M. Mohammed Riyas, M. P. Narmadha, Dinesh Balakrishnan. Defying Damage: Insights into Ischemic Reperfusion Injury in Liver Transplantation. Indian Journal of Transplantation 2025; 19(4) doi: 10.4103/ijot.ijot_22_25
|
| 17 |
Sara Maher, Shimaa Atta, Manal Kamel, Olfat A. Hammam, Hend Okasha. Therapeutic Potential and Mechanistic Insights of a Novel Synthetic α-Lactalbumin-Derived Peptide for the Treatment of Liver Fibrosis. Journal of Clinical and Experimental Hepatology 2025; 15(3) doi: 10.1016/j.jceh.2024.102488
|
| 18 |
Chan Mo, Zhuolin Wei, Jinnan He, Yuan Liu, Jiaorong Zheng, Min Hong, Yuhong Song. Unveiling the Immunopharmacological Mechanisms of Biejiajian Pills (BJJP) Underlying the Treatment of Hepatic Fibrosis: Insights From Network Pharmacology and Experimental Validation. Food Science & Nutrition 2026; 14(3) doi: 10.1002/fsn3.71683
|
| 19 |
Hendra Susanto, Inriana Candra Melani, Diajeng Ravika Adil Bangun Negara, Wafiq Azizah Nurfadila, Khulud Rizqi Azizah, Hasnawati Zahira, Nik Ahmad Nizam Nik Malek, A. Taufiq, H. Susanto, H. Nur, M. Diantoro, M. Aziz, N.A.N.N. Malek. Moringa oleifera Seed Oil (MOSEIL) Reduce CTGF (Connective Tissue Growth Factor) Gene Expression in Mice (Mus musculus) Liver Fibrosis Models. BIO Web of Conferences 2025; 183 doi: 10.1051/bioconf/202518301008
|
| 20 |
Watunyoo Buakaew, Sucheewin Krobthong, Yodying Yingchutrakul, Pachuen Potup, Yordhathai Thongsri, Krai Daowtak, Antonio Ferrante, Kanchana Usuwanthim. Investigating the Antifibrotic Effects of β-Citronellol on a TGF-β1-Stimulated LX-2 Hepatic Stellate Cell Model. Biomolecules 2024; 14(7) doi: 10.3390/biom14070800
|
| 21 |
Kaiqiang Wan, Qiong Zhou, Ruirui Feng, Tao Liu, Chang Fan, Xue Pang, Zhongliang Li, Qiumei Zhou. Construction of a HSC activation-related lncRNA–miRNA–mRNA ceRNA regulatory network reveals potential molecules involved in liver fibrosis. Frontiers in Genetics 2025; 16 doi: 10.3389/fgene.2025.1640326
|
| 22 |
Man Na, Xingbiao Yang, Yongkun Deng, Zhaoheng Yin, Mingwei Li. Endoplasmic reticulum stress in the pathogenesis of alcoholic liver disease. PeerJ 2023; 11 doi: 10.7717/peerj.16398
|
| 23 |
Florian Rieder, Laura E. Nagy, Toby M. Maher, Jörg H. W. Distler, Rafael Kramann, Boris Hinz, Marco Prunotto. Fibrosis: cross-organ biology and pathways to development of innovative drugs. Nature Reviews Drug Discovery 2025; 24(7) doi: 10.1038/s41573-025-01158-9
|
| 24 |
Noha M. Gamil, Habiba A. Elsayed, Esraa T. Salah, Heba A. Mostafa, Riham A. El-Shiekh, Heba R. Ghaiad, Hebatollah E. Eitah. Decoding the mechanistic basis of liver–muscle communication in health and disease. Naunyn-Schmiedeberg's Archives of Pharmacology 2026; 399(8) doi: 10.1007/s00210-026-05015-3
|
| 25 |
Galit Weinstein, Yochai Schonmann, Hanny Yeshua, Shira Zelber‐Sagi. The association between liver fibrosis score and incident dementia: A nationwide retrospective cohort study. Alzheimer's & Dementia 2024; 20(8) doi: 10.1002/alz.14033
|
| 26 |
Yutong Zhou, Yong Sun, Pengsheng Yin, Shi Zuo, Haiyang Li, Kun Cao. Bacterial extracellular vesicles: emerging mediators of gut-liver axis crosstalk in hepatic diseases. Frontiers in Cellular and Infection Microbiology 2025; 15 doi: 10.3389/fcimb.2025.1620829
|
| 27 |
Armin Mokhtariye, Jaleh Varshosaz, Adel Mohammadalipour, Mohammad Hashemnia, Mohammad Reza Mofid. Xanthosomes loaded with recombinant TMEM219 for targeting IGFBP-3: A novel approach for targeted drug delivery to ameliorate liver fibrosis. Life Sciences 2025; 377 doi: 10.1016/j.lfs.2025.123748
|
| 28 |
Samira Nomiri, Reyhaneh Taebi, Yaser Mohammadi, Tooba Yousefi, Fatemeh Asgari, Farzaneh Yazdanimoghaddam, Nafiseh Mortazavi, Abdollah Amini. Hepatoprotective effects of cinnamic acid against carbon tetrachloride–induced liver injury in a mouse model. Molecular Biology Reports 2026; 53(1) doi: 10.1007/s11033-026-12643-8
|
| 29 |
Ayan Saha, Emily Wood, Luna Omeragic, Maya Minkara, Kethain Marma, Shipan Das Gupta, Jannatul Ferdoush. Farnesoid X Receptor (FXR) Agonists and Protein Kinase Regulation in NAFLD and NASH: Mechanisms and Therapeutic Potential. Kinases and Phosphatases 2025; 3(3) doi: 10.3390/kinasesphosphatases3030016
|
| 30 |
Peyman Kheirandish Zarandi, Mohsen Ghiasi, Mohammad Heiat. The role and function of lncRNA in ageing-associated liver diseases. RNA Biology 2025; 22(1) doi: 10.1080/15476286.2024.2440678
|
| 31 |
Mohammadjavad Sotoudeheian. Galectin-3 and Severity of Liver Fibrosis in Metabolic
Dysfunction-Associated Fatty Liver Disease. Protein & Peptide Letters 2024; 31(4) doi: 10.2174/0109298665301698240404061300
|
| 32 |
Peng Ji, Yaru Li, Yufan Jin, Yuxuan Dong, Luzixuan Li, Ziyan Ma, Lingling Liu, Yazhuo Zhang, Zhenkun Ren. Nanomedicine-Driven Modulation of Signaling Pathways in Hepatic Fibrosis. International Journal of Nanomedicine 2026; doi: 10.2147/IJN.S418132
|
| 33 |
Xiaowen Mao, Peng Chen, Palidan Wubur, Yi Liu, Yuan Zhao, Siwei Zhang, Na Guan, Bin Li. From mechanisms to anti-fibrotic drugs in hepatic stellate cell research: a global bibliometric analysis with patent and clinical perspectives (2000–2025). Frontiers in Pharmacology 2025; 16 doi: 10.3389/fphar.2025.1734449
|
| 34 |
Pasquale Rapacciuolo, Claudia Finamore, Cristina Di Giorgio, Bianca Fiorillo, Carmen Massa, Ginevra Urbani, Silvia Marchianò, Martina Bordoni, Chiara Cassiano, Elva Morretta, Lucio Spinelli, Antonio Lupia, Federica Moraca, Michele Biagioli, Valentina Sepe, Maria Chiara Monti, Bruno Catalanotti, Stefano Fiorucci, Angela Zampella. Design, Synthesis, and Pharmacological Evaluation of Dual FXR-LIFR Modulators for the Treatment of Liver Fibrosis. Journal of Medicinal Chemistry 2024; 67(20) doi: 10.1021/acs.jmedchem.4c01651
|
| 35 |
Jianzhong Song, Xin Zhao, Lingling Cao, Yingying Chen, Xingchen Zhou, Jinfa Li, Peijin You, Jing Zhou, Zhiyuan Lv, Xiumin Ma, Junmin Chang. Alhagi honey polysaccharide ameliorates carbon tetrachloride-induced liver fibrosis via modulating the gut microbiota-liver metabolism axis. Frontiers in Nutrition 2026; 13 doi: 10.3389/fnut.2026.1862546
|
| 36 |
N. E. Veselova, V. V. Tsukanov, A. A. Savchenko, A. V. Vasyutin, Ju. L. Tonkikh, Ya. E. Fursova. Association of clinical manifestations of Opisthorchis felineus invasion with elevated FIB-4 index levels. Meditsinskiy sovet = Medical Council 2025; (8) doi: 10.21518/ms2025-216
|
| 37 |
Gregory Simchick, James Rice, Leah M. Gober, Daniel Rice, Jennifer Philip, Alejandro Roldan‐Alzate, Diego Hernando. Validation of Intravoxel Incoherent Motion MRI Using Perfused Explanted Human Livers. Magnetic Resonance in Medicine 2026; 95(4) doi: 10.1002/mrm.70184
|
| 38 |
Varshni Premnath, Shanthi Veerappapillai. Polypharmacological Exploration of Petroselinum Crispum for Antifibrotic Therapeutics: from Herb to Hepatoprotection. Applied Biochemistry and Biotechnology 2026; 198(3) doi: 10.1007/s12010-025-05547-z
|
| 39 |
Hong Zhang, Xin Liu, Yan Liu, Dacai Gong, Min Lai, Bin Ge, Dan Wang, Mingsheng Tan, Peng Chen. Identification of PANoptosis-related gene SIK1 in MASLD by bioinformatics, machine learning and experimental validation. Biochemical and Biophysical Research Communications 2026; 827 doi: 10.1016/j.bbrc.2026.154019
|
| 40 |
Vasilii Slautin, Konstantin Konyshev, Ilya Gavrilov, Olga Beresneva, Irina Maklakova, Dmitry Grebnev. Fucoxanthin Enhances the Antifibrotic Potential of Placenta-derived Mesenchymal Stem Cells in a CCl4-induced Mouse Model of Liver. Current Stem Cell Research & Therapy 2024; 19(11) doi: 10.2174/011574888X279940231206100902
|
| 41 |
Feng Chen, Qianhui Li, Xiaomin Xu, Fei Wang. Non-invasive Diagnostic Indicators and Antiviral Treatment Efficacy in CHB Patients with Different Liver Histopathological Degrees. Hepatitis Monthly 2024; 24(1) doi: 10.5812/hepatmon-147016
|
| 42 |
Xiaodong Li, Nana Li, Yujie Wang, Qixiang Han, Boshi Sun. Research Progress of Fibroblasts in Human Diseases. Biomolecules 2024; 14(11) doi: 10.3390/biom14111478
|
| 43 |
Daisuke Taguchi, Yohei Shirakami, Hiroyasu Sakai, Toshihide Maeda, Takao Miwa, Masaya Kubota, Kenji Imai, Takashi Ibuka, Masahito Shimizu. High-Fat Diet Delays Liver Fibrosis Recovery and Promotes Hepatocarcinogenesis in Rat Liver Cirrhosis Model. Nutrients 2024; 16(15) doi: 10.3390/nu16152506
|
| 44 |
Tamer A. Addissouky. Personalized Pain Pathways in Liver Fibrosis: Towards Precision Hepatology. Avicenna Journal of Medical Biochemistry 2024; 12(2) doi: 10.34172/ajmb.2535
|
| 45 |
Maryam Mahjoubin-Tehran, Samaneh Rezaei, Prashant Kesharwani, Sercan Karav, Amirhossein Sahebkar. Decoy oligodeoxynucleotides targeting STATs in non-cancer gene therapy. Gene 2025; 957 doi: 10.1016/j.gene.2025.149482
|
| 46 |
Megha Mayavanshi, Chintan Thacker, Brijesh Vala. A Review on Ultrasound-based Liver Disease Classification using Deep Neural Networks. 2025 International Conference on Sustainable Communication Networks and Application (ICSCN) 2025; doi: 10.1109/ICSCN67106.2025.11308477
|
| 47 |
Leonardo Halamy Pereira, Pedro Bicudo Bregion, Victor Kenzo Ivano, Fernando de Barros, Gabriel José Souto Maior de França, Giovanna Macanhã Scremin, Julia Bueno de Oliveira Alves, Luísa Zanelatto de Araújo, Pandora Eloá Oliveira Fonseca, João Gabriel Romero Braga, Everton Cazzo. Efficacy of Roux-en-Y Gastric Bypass and Sleeve Gastrectomy on Hepatic Steatosis and Fibrosis Markers: A Meta-analysis of Randomized Clinical Trials. Obesity Surgery 2025; 35(10) doi: 10.1007/s11695-025-08274-w
|
| 48 |
Miguel Jiménez‑Luévano, Ana Jiménez‑Partida, Erick Sierra‑Díaz, Eduardo Orozco‑Alonso, Martha Villaseñor‑García, Alejandro Bravo‑Hernández, Jesús Gutiérrez‑Ortíz, Alejandro Bravo‑Cuellar, Georgina Hernández‑Flores. Prolonged use of pentoxifylline increases the life expectancy of patients with compensated cirrhosis: A 20‑year retrospective study. Biomedical Reports 2024; 21(6) doi: 10.3892/br.2024.1861
|
| 49 |
Vasudevan Sekar, Venkateish VP, Vani Vijay, Annapoorna BR, Nivya Vijayan, Madan Kumar Perumal. Inhibition of hepatic stellate cell activation by nutraceuticals: an emphasis on mechanisms of action. Journal of Food Science and Technology 2024; 61(11) doi: 10.1007/s13197-024-06002-3
|
| 50 |
Hao-Chien Hung, Ainani Priza Minhalina, Po-Jung Hsu, Ke-Hung Tsui, Ting-Yen Chao, Chao Lien Liu. Targeted attenuation of liver fibrosis using microbubble-enhanced protease-activated receptor 1 chimeric antigen receptor T cells. Biomedicine & Pharmacotherapy 2026; 201 doi: 10.1016/j.biopha.2026.119703
|
| 51 |
Xueqing Huang, Jiaqi Xie, Li Yin, Keli Zhou, Xiaoyu Peng, Shiqi Chen, Jiayue Xu, Hongdao Chen, Dehui Yin, Shouzhong Ren, Ye Zhu. Jiangcaoxiang alleviates hepatic fibrosis through the Nrf2/GPX4 signaling pathway: Elucidated via integrated network pharmacology, multi-omics profiling, and experimental validation. Fitoterapia 2026; 191 doi: 10.1016/j.fitote.2026.107192
|
| 52 |
Sisi Yang, Riccardo Sartoris, Yann Teyssier, Alexandre Bône, Maxime Ronot, Thomas Decaens, Joan Alexis Glaunès, Christophe Aubé. Auto-LSN: fully automated liver surface nodularity quantification in CT based on deep learning for the evaluation of advanced chronic liver disease. European Radiology 2026; 36(6) doi: 10.1007/s00330-026-12346-5
|
| 53 |
Peng Ji, Yan Li, Zihan Wang, Siyu Jia, Xinyi Jiang, Hui Chen, Qun Wang. Advances in precision gene editing for liver fibrosis: From technology to therapeutic applications. Biomedicine & Pharmacotherapy 2024; 177 doi: 10.1016/j.biopha.2024.117003
|
| 54 |
Chun-Ye Zhang, Ming Yang. Artificial intelligence in liver disease: Current status and future direction. Artificial Intelligence in Cancer 2026; 7(1): 119655 doi: 10.35713/aic.119655
|
| 55 |
Ming Yang, Chun-Ye Zhang. Interleukins in liver disease treatment. World Journal of Hepatology 2024; 16(2): 140-145 doi: 10.4254/wjh.v16.i2.140
Abstract(846) |
Core Tip(783) |
Full Article(HTML)(4058)
|
Full Article (PDF)-371K(273)
|
Full Article with Cover (PDF)-881K(230)
|
Full Article (Word)-128K(30)
|
Full Article (XML)-84K(161)
|
Audio-129K(16)
|
Peer-Review Report-180K(178)
|
Answering Reviewers-111K(161)
|
Times Cited (0)
|
Total Visits (5333)
|
Open
|
| 56 |
A. V. Vasyutin, V. V. Tsukanov, N. E. Veselova, E. G. Gorchilova, J. L. Tonkikh, A. A. Savchenko, A. G. Borisov. Association of neutropenia and decreased neutrophil function with liver fibrosis in patients with Opisthorchis felineus invasion. Meditsinskiy sovet = Medical Council 2024; (15) doi: 10.21518/ms2024-339
|
| 57 |
Tamer A. Addissouky, Majeed M. A. Ali, Ibrahim El Tantawy El Sayed, Yuliang Wang. Emerging advanced approaches for diagnosis and inhibition of liver fibrogenesis. The Egyptian Journal of Internal Medicine 2024; 36(1) doi: 10.1186/s43162-024-00283-y
|
| 58 |
Devadoss J. Samuvel, John J. Lemasters, C. James Chou, Zhi Zhong. LP340, a novel histone deacetylase inhibitor, decreases liver injury and fibrosis in mice: role of oxidative stress and microRNA-23a. Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1386238
|
| 59 |
Yashaswini A, Mamatha Sri S, Mamatha V Rao. A THERAPEUTIC INSIGHT ON MUTRAVIRAJANEEYA MAHAKASHAYA IN HE-PATIC FIBROSIS – A LITERATURE REVIEW. International Ayurvedic Medical Journal 2025; doi: 10.46607/iamj2813102025
|
| 60 |
Svetlana Rodimova, Lidia Mikhailova, Konstantin Arabuli, Dmitry Kozlov, Vera Kozlova, Dmitry Kuzmin, Ilya Shchechkin, Nikolai Bobrov, Artem Mozherov, Vladimir Zagainov, Peter Timashev, Elena Zagaynova, Daria S. Kuznetsova, Mikhail V. Zyuzin. MicroRNA-200a as a therapeutic agent for acute and chronic liver pathologies and regeneration. Biomaterials 2026; 331 doi: 10.1016/j.biomaterials.2026.124125
|
| 61 |
Jia Ming Nickolas Teo, Guang Sheng Ling. Sphingosine Kinase 1 – A Therapeutic Opportunity for Alleviating Liver Fibrosis?. Cellular and Molecular Gastroenterology and Hepatology 2025; 19(2) doi: 10.1016/j.jcmgh.2024.101430
|
| 62 |
Chun-Ye Zhang, Ming Yang. Emerging treatment options for metabolic dysfunction-associated steatotic liver disease and its related liver diseases. World Journal of Hepatology 2026; 18(6): 120178 doi: 10.4254/wjh.120178
|
| 63 |
Vallabh Mulay, Arun Kumar Balasubramaniam, Ganesh Saste, Lal Hingorani. Natural Product Drugs. 2025; doi: 10.1039/9781837676989-00467
|
| 64 |
Sara T. Elazab, Walter H. Hsu. Ferulic acid ameliorates concanavalin A-induced hepatic fibrosis in mice via suppressing TGF-β/smad signaling. Toxicology and Applied Pharmacology 2024; 492 doi: 10.1016/j.taap.2024.117099
|
| 65 |
Guo-Feng Gao, Jiao Yu, Lin Tong, Dong Jiang. Predictive value of core-fucosylated low-molecular-weight kininogen levels in patients with liver fibrosis: A prospective study. World Journal of Gastroenterology 2025; 31(29): 105210 doi: 10.3748/wjg.v31.i29.105210
|
| 66 |
Ming Yang, Chun-Ye Zhang. Molecular mechanisms of tumor-associated macrophages in hepatocellular carcinoma development and therapy. World Journal of Gastroenterology 2026; 32(8): 115675 doi: 10.3748/wjg.v32.i8.115675
|
| 67 |
Simona Cernea. NAFLD Fibrosis Progression and Type 2 Diabetes: The Hepatic–Metabolic Interplay. Life 2024; 14(2) doi: 10.3390/life14020272
|
| 68 |
Akshaya V. Annapragada, Zachariah H. Foda, Hope Orjuela, Carter Norton, Shashikant Koul, Noushin Niknafs, Sarah Short, Keerti Boyapati, Adrianna Bartolomucci, Dimitrios Mathios, Michael Noë, Chris Cherry, Jacob Carey, Alessandro Leal, Bryan Chesnick, Nicholas C. Dracopoli, Jamie E. Medina, Nicholas A. Vulpescu, Daniel C. Bruhm, Sarah Bacus, Vilmos Adleff, Amy K. Kim, Stephen B. Baylin, Gregory D. Kirk, Andrei Sorop, Razvan Iacob, Speranta Iacob, Liana Gheorghe, Simona Dima, Manuel Ramírez-Zea, Katherine A. McGlynn, Claus L. Feltoft, Julia S. Johansen, John Groopman, Jillian Phallen, Robert B. Scharpf, Victor E. Velculescu. Cell-free DNA fragmentomes for noninvasive detection of liver cirrhosis and other diseases. Science Translational Medicine 2026; 18(839) doi: 10.1126/scitranslmed.adw2603
|
| 69 |
Hee Won Park, Dae Hyun Lee, Sungjun Kim, Hyeri Park, Ashok Kumar Jangid, Chae Eun Lee, Jaewon Park, Gyu Tae Park, Ha Yeon Park, HyunJin Kim, Jae Ho Kim, Gi Jin Kim, Kyobum Kim. Amphiphilic lipid-peptide engineered placenta-derived mesenchymal stem cells for liver fibrosis treatment. Asian Journal of Pharmaceutical Sciences 2025; 20(4) doi: 10.1016/j.ajps.2025.101061
|
| 70 |
Xiaozheng Zhang, Guicai Wu, Sili Peng, Haoran Xu, Kai Li, Tingjuan Huang, Zhizhen Liu.
Bicuculline from
Forsythia suspensa
attenuates liver fibrosis via TLR4/MD2 inhibition and suppression of MyD88/NF-κB signaling
. Computational and Structural Biotechnology Journal 2026; 31 doi: 10.1016/j.csbj.2025.12.026
|
| 71 |
Hadis Gerami, Hassan Mozaffari-Khosravi, Asieh Mansour, Amir Ali Sohrabpour, Hossein Poustchi, Amir Pejman Hashemi Taheri, Mahmoud Reza Jaafari, Sara Jambarsang, Sayyed Saeid Khayyatzadeh. Efficacy of the nano curcumin supplementation on fibrosis, steatosis, inflammatory and metabolic status of liver fibrosis patients with non-alcoholic fatty liver origin: a study protocol for a double-blind randomized controlled trial. BMC Nutrition 2026; 12(1) doi: 10.1186/s40795-026-01252-0
|
| 72 |
Mohammad Aabis, Priyanka Tiwari, Vinod Kumar, Gurpreet Singh, Archana Panghal, Gopabandhu Jena. Pentadecanoic acid attenuates thioacetamide-induced liver fibrosis by modulating oxidative stress, inflammation, and ferroptosis pathways in rat. Naunyn-Schmiedeberg's Archives of Pharmacology 2025; 398(11) doi: 10.1007/s00210-025-04143-6
|
| 73 |
Joey A. Muns, Erik Schooten, Rychon D. J. van Dasselaar, Yvet E. Noordman, Kevin Adamzek, Arthur C. Eibergen, Sebas D. Pronk, Sagel Cali, Niels J. Sijbrandi, Eugen Merkul, Sabrina Oliveira, Paul M.P. van Bergen en Henegouwen, R. Bart Takkenberg, Joanne Verheij, Stan F.J. van de Graaf, Bart A. Nijmeijer, Guus A.M.S. van Dongen. Preclinical targeting of liver fibrosis with a 89Zr-labeled Fibrobody® directed against platelet derived growth factor receptor-β. European Journal of Nuclear Medicine and Molecular Imaging 2024; 51(12) doi: 10.1007/s00259-024-06785-9
|
| 74 |
Mohd Danish, Riaz Ahmad. Investigation on the mechanistic approach of trigonelline action in attenuating nitrosodiethylamine instigated rodent experimental liver injury. The Journal of Basic and Applied Zoology 2025; 86(1) doi: 10.1186/s41936-025-00514-w
|
| 75 |
Weidong Shao, Hui Xu, Kanghua Zeng, Mingzhou Ye, Renjun Pei, Kai Wang. Advances in liver organoids: replicating hepatic complexity for toxicity assessment and disease modeling. Stem Cell Research & Therapy 2025; 16(1) doi: 10.1186/s13287-025-04139-2
|
| 76 |
Favour Balogun, Shreya Honarius, Megan Li Yuen Yeoh, Mahmoud Abouibrahim, Mostafa Sayed, Joanne Randall. Adult-Onset Diabetes and Liver Fibrosis as Diagnostic Clues to Alström Syndrome: A Case Report. Cureus 2026; doi: 10.7759/cureus.102959
|
| 77 |
Wiebke‐Felicitas Nierath, Emily Leitner, Sabrina Reimann, Rico Schwarz, Burkhard Hinz, André Bleich, Brigitte Vollmar, Dietmar Zechner. GSK805 inhibits alpha‐smooth muscle expression and modulates liver inflammation without impairing the well‐being of mice. The FASEB Journal 2024; 38(16) doi: 10.1096/fj.202400733R
|
| 78 |
Tao Wang, Yi Jiang, JianFeng Zhang, WeiMin Li, HuiXin Xue, HaiYong Hua, Wei Wang, Kun Yang. Development and validation of a machine learning-based model for identifying liver fibrosis in individuals with prior Schistosoma japonicum infection: a step toward precision management. Infectious Diseases of Poverty 2026; 15(1) doi: 10.1186/s40249-026-01485-y
|
| 79 |
Dimitrios Nikolakis, Andrew Y F Li Yim, Kenneth L Overberg, Mohammed Ghiboub, Manon E Wildenberg, Wouter J de Jonge, Dalia Lartey, Florian Rieder , Geert R D’Haens, Marleen G H van de Sande, Mark Löwenberg. Drug repurposing approach for the discovery of therapeutic agents for Crohn’s disease-associated intestinal fibrosis. Journal of Crohn’s and Colitis 2025; 19(9) doi: 10.1093/ecco-jcc/jjaf137
|
| 80 |
Wenze Zhang, Jiwei Li, Lei Sun, Chaoran Li, Kaiyu Zhang, Zhiying He, Guangyi Yang, Boyang Yu, Fengguo Xu, Haijun Xu, Xianchuang Zheng, Jiangwei Tian. Molecular imaging-guided discovery of a potent natural FAPα inhibitor for liver fibrosis therapy. Nature Communications 2026; 17(1) doi: 10.1038/s41467-026-75493-9
|
| 81 |
Maryam Jadid Tavaf, Saeid Abroun, Mahdieh Hashemi, Ibrahim Ghoytasi, Abbas Piryaei, Masoud Soleimani, Ali Zarrabi, Massoud Vosough. Cord-blood-PRP attenuates fibrogenic features of TGFβ-activated hepatic stellate cells in in vitro and animal models. Bioorganic Chemistry 2026; 174 doi: 10.1016/j.bioorg.2026.109748
|
| 82 |
Zahid Hussain. Mesenchymal stem cell and exosome-based therapy for liver diseases: can it overcome conventional therapeutic inconsistencies?. Exploration of Digestive Diseases 2025; 4 doi: 10.37349/edd.2025.100563
|
| 83 |
Przemysław Niziński, Anna Krajewska, Tomasz Oniszczuk, Beata Polak, Anna Oniszczuk. Hepatoprotective Effect of Kaempferol—A Review. Molecules 2025; 30(9) doi: 10.3390/molecules30091913
|
| 84 |
Xiao-Ling Wang, Meng Yang, Ying Wang. Roles of transforming growth factor-β signaling in liver disease. World Journal of Hepatology 2024; 16(7): 973-979 doi: 10.4254/wjh.v16.i7.973
|
| 85 |
Xin Chen, Guangmin Zhang, Ziwen Qiao, Sudan Zhang, Lijuan Chen, Huimin Wang, Min Qiu, Wenpeng Yuan, Jiane Liu, Zheng Wang, Chunqing Zhang, Guangchuan Wang. Glucosamine alleviates liver fibrosis through modulation of sinusoidal blood flow and hepatic immune responses. Biomedicine & Pharmacotherapy 2025; 188 doi: 10.1016/j.biopha.2025.118180
|
| 86 |
Shradha P Kakde, Maham Mushtaq, Maryyam Liaqat, Husnain Ali, Muhammad Muaz Mushtaq, Muhammad Asad Sarwer, Sami Ullah, Muhammad Wali Hassan, Asma Khalid, Syed Faqeer Hussain Bokhari. Emerging Therapies for Non-Alcoholic Steatohepatitis (NASH): A Comprehensive Review of Pharmacological and Non-Pharmacological Approaches. Cureus 2024; doi: 10.7759/cureus.69129
|
| 87 |
Xiaoxin Liu, Ninglin Xia, Qinwei Yu, Ming Jin, Zifan Wang, Xue Fan, Wen Zhao, Anqin Li, Zhenzhou Jiang, Luyong Zhang. Silybin Meglumine Mitigates CCl4-Induced Liver Fibrosis and Bile Acid Metabolism Alterations. Metabolites 2024; 14(10) doi: 10.3390/metabo14100556
|
| 88 |
Komsan Arramrak, Namthip Witayavanitkul, Maneerat Chayanupatkul, Natcha Wanpiyarat, Prasong Siriviriyakul, Duangporn Werawatganon, Ze Xiang. Calcitriol attenuates diethylnitrosamine-induced hepatic fibrosis in rats by reducing oxidative stress and fibrogenic mediators. PLOS One 2026; 21(5) doi: 10.1371/journal.pone.0347908
|